By establishing a humanized severe combined immunodeficiency IPF model, Geng et al. suggested that targeting PD-L1 during the early and late stages might significantly reduce the invasion of IPF fibroblasts and could not only eliminate the progression of pulmonary fibrosis but also reverse it [21]. The gene discussed is CD274; the disease is idiopathic pulmonary fibrosis.